Posted on October 22, 202010/22/20
Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.
Posted on October 20, 202010/20/20
UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis
Posted on October 12, 202010/12/20
Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines
Posted on August 25, 20208/25/20
Medicine Prices Remain Unchanged in Pakistan
Posted on August 19, 20208/19/20
China Publishes Working Plan for 2020 NRDL Update, Revised List Expected December 2020
Posted on August 19, 20208/19/20
The Netherlands’ New IRP to Take Effect October 1
Posted on July 21, 20207/21/20
Pharma No Longer Allowed Annual Price Increases for Certain Medicines in Pakistan
Posted on July 14, 20207/14/20
Panama’s Agencies, Drugstores & Labs Allowed to Import COVID-19 Drugs
Posted on June 30, 20206/30/20